MedPath

南京正科医药股份有限公司

Ownership
-
Established
2001-07-30
Employees
-
Market Cap
-
Website
http://www.zenkom.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

Sodium Potassium Magnesium and Calcium Concentrated Solution for Injection

Product Name
钠钾镁钙注射用浓溶液
Approval Number
国药准字H20253750
Approval Date
Apr 1, 2025
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20253538
Approval Date
Mar 4, 2025
NMPA

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20244025
Approval Date
Jun 18, 2024
NMPA

Dexmedetomidine Hydrochloride Injection

Product Name
盐酸右美托咪定注射液
Approval Number
国药准字H20243550
Approval Date
Apr 24, 2024
NMPA

Dexmedetomidine Hydrochloride Injection

Product Name
盐酸右美托咪定注射液
Approval Number
国药准字H20243549
Approval Date
Apr 24, 2024
NMPA

Torasemide Injection

Product Name
托拉塞米注射液
Approval Number
国药准字H20247068
Approval Date
Apr 16, 2024
NMPA

Sodium Phosphates Oral Solution

Product Name
磷酸钠盐口服溶液
Approval Number
国药准字H20193245
Approval Date
Mar 8, 2024
NMPA

Esmolol Hydrochloride Injection

Product Name
盐酸艾司洛尔注射液
Approval Number
国药准字H20243275
Approval Date
Feb 23, 2024
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20234540
Approval Date
Nov 21, 2023
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20234541
Approval Date
Nov 21, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.